Trial intelligence / Profile preview

Clomiphene Citrate in Uncontrolled Acromegaly

NCT02274311Phase 2Completed

Start
Jan 2011
Primary completion
Oct 2014
Modality
Small Molecules
01

Overview

Phase 2, open-label, single-arm trial of clomiphene in acromegaly. Primary endpoint: Serum Insulin Like Growth Factor 1 Levels at Day 90. Started Jan 2011; status: completed.

02

Drugs

clomiphene
03

Conditions

acromegaly

Beyond the preview

Go deeper on NCT02274311.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02274311.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call